首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   26465篇
  免费   1552篇
  国内免费   832篇
耳鼻咽喉   126篇
儿科学   375篇
妇产科学   265篇
基础医学   1834篇
口腔科学   836篇
临床医学   3312篇
内科学   4934篇
皮肤病学   112篇
神经病学   1594篇
特种医学   1728篇
外国民族医学   3篇
外科学   3778篇
综合类   3598篇
现状与发展   2篇
预防医学   487篇
眼科学   3386篇
药学   1450篇
  9篇
中国医学   536篇
肿瘤学   484篇
  2024年   60篇
  2023年   457篇
  2022年   769篇
  2021年   1025篇
  2020年   945篇
  2019年   854篇
  2018年   805篇
  2017年   824篇
  2016年   852篇
  2015年   905篇
  2014年   1546篇
  2013年   1616篇
  2012年   1452篇
  2011年   1593篇
  2010年   1404篇
  2009年   1336篇
  2008年   1412篇
  2007年   1364篇
  2006年   1300篇
  2005年   1075篇
  2004年   928篇
  2003年   849篇
  2002年   653篇
  2001年   557篇
  2000年   459篇
  1999年   410篇
  1998年   405篇
  1997年   378篇
  1996年   255篇
  1995年   282篇
  1994年   251篇
  1993年   205篇
  1992年   176篇
  1991年   160篇
  1990年   124篇
  1989年   121篇
  1988年   118篇
  1987年   101篇
  1986年   94篇
  1985年   114篇
  1984年   103篇
  1983年   59篇
  1982年   78篇
  1981年   81篇
  1980年   55篇
  1979年   57篇
  1978年   57篇
  1977年   35篇
  1976年   28篇
  1975年   16篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
Antiarrhythmic effects of phosphorylated glycolysis intermediates glucose-1-phosphate, fructose-1,6-diphosphate, and phosphoenolpyruvate in early postocclusion arrhythmias are shown in rat experiments; in contrast to these, D-glucose, sodium pyruvate, and monoiodacetate, a glycolysis inhibitor, exert no appreciable antiarrhythmic effect. Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 117, N o 6, pp. 625–626, June, 1994 Presented by P. V. Sergeev, Member of the Russian Academy of Medical Sciences.  相似文献   
82.
分析了7岁以下儿童视网膜脱离(RD)21例。儿童裂孔源性RD主要由外伤引起,非裂孔源性RD多与遗传、发育异常、Coat's病、眼内感染等因素有关。本文还讨论了儿童外伤性RD的临床特点和预防措施,强调了孕产期妇女保健对预防儿童非外伤性RD的意义。  相似文献   
83.
We report on a 52-year old male patient who underwent implantation of an insulin pump because he had diabetes and in whom superior vena cava syndrome developed as a long-term complication. After unsuccessful lysis therapy superficial femoral vein was implanted to form a bypass from the internal jugular vein to the right atrium. The postoperative course was uneventful from the aspects of both the bypass and the leg after explantation of the superficial femoral vein. The bypass is still patent 7 months after the operation, and the patient has no symptoms. Autogenous superficial femoral vein can be used successfully in the reconstruction of large venous vessels. It should be the graft of choice for young patients with benign diseases. We compare our result and those obtained with different substitutes described in the literature that have been used for reconstruction in superior vena cava syndrome.
Die verwendung der autologen vena femoralis bei vena-cava-superior-thromboseFallbericht mit literaturübersicht
Zusammenfassung Bei einem 52jährigen, männlichen Patienten trat nach Implantation einer Insulinpumpe als Spätkomplikation eine Thrombose der Vena cava superior auf. Nach erfolgloser Lysetherapie wurde ein Venajugularis-rechtsatrialer-Venenbypass mit autologer Vena femoralis durchgeführt. Der postoperative Heilungsverlauf war sowohl von Seiten des gefäßrekonstruktiven Eingriffs, als auch von Seiten der Venenentnahmestelle komplikationslos. Der Bypass ist 7 Monate postoperativ offen und der Patient beschwerdefrei. Die autologe Vena femoralis eignet sich zur Rekonstruktion großer venöser Gefäße ausgezeichnet. Sie sollte v. a. bei benignen Prozessen und jüngeren Patienten als autologes Bypassmaterial dem Kunststoff vorgezogen werden. Das Ergebnis wird mit verschiedenen Gefäßsubstituten, die bei Verschluß der oberen Hohlvene verwendet werden, verglichen.
  相似文献   
84.
A decrease in ostial pulmonary vein (PV) diameter was observed in patients on the day after radiofrequency ablation of atrial fibrillation (AF). This study examined whether a relative reduction in PV diameter on day 1 (RRPVD1) after the procedure predicts the late development of severe PV stenosis (PVS). The study included 104 consecutive patients (mean age = 55 years, range 46–61, 34 women) with drug refractory AF. Pulmonary vein diameter was measured using MR angiography (MRA) on the day before and on day 1 after the ablation procedure. The MRA was repeated every 3 months after the procedure. Severe PVS was defined as a >70% diameter reduction from the initial ostial diameter. The cut-off of RRPVD1 was prespecified as 25% decrease in initial diameter. The data are presented as medians and interquartile range. A total of 357 PV were treated. The RRPVD1 was 0.0% (0.0–11.1%). Severe PVS was found in 18 PV during a follow-up of 12 months (range 6–13). The log-rank analysis confirmed a strong association between a RRPVD1 ≥25% and the development of PVS (hazard ratio: 7.1; 95% confidence interval 3.8–13.5, P < 0.0001). By multivariate Cox regression model, after adjustment of procedure variables, RRPVD1 was the strongest predictor of development of severe PVS. RRPVD1 ≥25% was a strong independent predictor of development of severe PVS.  相似文献   
85.
下腔静脉滤器在治疗下肢深静脉血栓中的应用   总被引:1,自引:1,他引:0  
目的:探讨下腔静脉滤器在治疗下肢深静脉血栓(DVT)中的应用价值。方法:选择10例DVT患,使用进口铁质滤器,经股静脉或颈静脉途径置人下腔静脉,随访8—20个月。结果:10例患中无一例发生肺动脉栓塞和其他严重并发症。结论:下腔静脉滤器置人方法简单,安全;可有效防止肺动脉栓塞的发生。  相似文献   
86.
Cardiac malignant mesenchymoma is an extremely rare malignancy with poor prognosis. We report a patient presenting with a history and clinical findings typical of mitral stenosis. Transthoracic echocardiography showed a mass on the thickened posterior mitral leaflet. Transoesophageal echocardiography revealed two tumoural masses: one on the atrial side of the posterior mitral leaflet causing mitral obstruction, the other arising in the region of the right lower pulmonary vein orifice and obstructing inflow through this vein.  相似文献   
87.
We present two patients with angulated, proximal left circumflex lesions, one a chronic total occlusion and one an acute subtotal occlusion. In both cases, use of the deflectable tip Venture Catheter (Velocimed, Minneapolis, MN) facilitated guide wire passage and successful percutaneous coronary intervention (PCI) after prior attempts at guide wire passage with standard wires were unsuccessful.  相似文献   
88.
Summary We have studied the results of carotid occlusion in the treatment of giant intracavernous carotid artery (ICA) aneurysms in 40 patients. Clinical, angiographic, Doppler and cerebral blood flow (CBF) criteria for tolerance of occlusion are discussed. The patients had headaches (47.5%), cranial nerve compression (87.5%), decreased visual acuity (20%), ruptured aneurysm (15%) and 5% were asymptomatic. Balloon occlusion tests were performed under light sedation anaesthesia: a successful test required perfect clinical tolerance and adequate angiographic collateral circulation in arterial, parenchymatous, and venous phases. Additional criteria include xenon 133 CBF measurements, and transcranial Doppler sonography of the middle cerebral artery. According to these criteria, 5 patients did not tolerate test occlusion and required an extra-intracranial (EC-IC) bypass. Mean follow-up was 4.7 years. All patients were radiologically cured of their ancurysm, and in 35 the symptoms resolved, although 3 had persistent ocular motor nerve palsies, and in 4 visual defects were unchanged. Complications were 1 permanent and 3 transient neurological deficits. Balloon occlusion of the ICA is an effective, reliable form of treatment for intracavernous giant aneurysm and should replace surgical ligation of the cervical carotid artery. With CBF or Doppler monitoring, the risk of neurological deficit is diminished. EC-IC bypass prior to ICA occlusion is indicated if test occlusion is not tolerated.  相似文献   
89.
Day-only admissions for surgery are strongly encouraged, in an effort to keep costs down. Varicose vein surgery has been considered too major for day-only management despite the fact that there have been studies from overseas showing that it can be done with a morbidity comparable to inpatient surgery. The morbidity of day-only surgery for varicose veins (both long and short saphenous procedures) was assessed and compared with the results of inpatient surgery. Patients were also asked whether they were satisfied with the surgery being done this way. There were 165 consecutive patients available for study, 64 day-only and 101 inpatient. All patients attending Shellharbour Hospital, Shellharbour, had surgery done as day-only (as it was a morning list and allowed adequate time for recovery). Patients attending Bulli Hospital, Bulli, had surgery done as an inpatient (afternoon list). All surgery was performed by one surgeon. There was no difference (Chi-squared) in the age distribution (mean 48 years for day-only, 51 years for inpatient) or sex proportion in either group (Chi-squared test of proportions with continuity correction). Assessment of the results was done by review of the surgeon's notes, as well as telephone interviews for day-only subjects. The complication rate in both groups was similar. Wound problems represented the main complication with an incidence of 10.5% in each group. There was one deep venous thrombosis (DVT) in each group (diagnosed by duplex scan). Response to the telephone interview suggested that most patients were happy to have the surgery done as a day-only procedure. Sixty-nine per cent responded that they would have it done this way again and 76% were satisfied with the result of the surgery. This study confirms the results of overseas studies, in that varicose vein surgery can be performed as day-only procedures with a complication rate similar to inpatient procedures and with a high degree of patient satisfaction. It is suggested that this should be used as the method of choice for the majority of patients requiring varicose vein surgery.  相似文献   
90.
伤肢小隐静脉修复腘动脉损伤解剖基础与临床应用   总被引:1,自引:0,他引:1  
目的:为利用伤肢小隐静脉修复腘动脉损伤提供解剖学依据。方法:对25具标本50侧肢体的腘动脉和小隐静脉进行解剖研究并分别测量其管径。结果:腘动脉与小隐静脉解剖关系恒定,腘动脉管径起始段为(6.6±0.9)mm,中段为(5.9±1.0)mm,分叉前为(4.9±0.9)mm,小隐静脉管径汇入处为(3.1±0.1)mm,外踝平面和中段管径均为(2.9±0.1)mm,在小腿的上段小隐静脉与大隐静脉和深静脉间交通支出现率低。结论:腘动脉与小隐静脉解剖关系恒定,管径较相近,在伤肢小腿的上段切取一段小隐静脉对静脉回流无明显影响,临床应用21例22侧肢体,效果可靠满意。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号